banter and General Discussion, page-5289

These are just ridiculous prices. The GVHD treatment is completely de-risked. Your buying a company that has been through the ringer with the FDA, met their CMC concerns, after hitting the ball out of the park with Phase 3 trials. To say nothing of their other blockbuster indications like CLBP and CHF, just to name a few.
As an investor when do you pull the trigger? Hoping for further falls after 10 years of grinding lower, or say this is close enough? I've personally invested heavily, including 10% of my Super in MSB. The naysayers have nothing. Take a serious look at MSB in '23. This stock really needs some positive marketing.